Literature DB >> 25115886

Accuracy of a novel auto-CPAP device to evaluate the residual apnea-hypopnea index in patients with obstructive sleep apnea.

Carlos Alberto Nigro1, Sergio González, Anabella Arce, María Rosario Aragone, Luciana Nigro.   

Abstract

BACKGROUND: Patients under treatment with continuous positive airway pressure (CPAP) may have residual sleep apnea (RSA).
OBJECTIVE: The main objective of our study was to evaluate a novel auto-CPAP for the diagnosis of RSA.
METHODS: All patients referred to the sleep laboratory to undergo CPAP polysomnography were evaluated. Patients treated with oxygen or noninvasive ventilation and split-night polysomnography (PSG), PSG with artifacts, or total sleep time less than 180 min were excluded. The PSG was manually analyzed before generating the automatic report from auto-CPAP. PSG variables (respiratory disturbance index (RDI), obstructive apnea index, hypopnea index, and central apnea index) were compared with their counterparts from auto-CPAP through Bland-Altman plots and intraclass correlation coefficient. The diagnostic accuracy of autoscoring from auto-CPAP using different cutoff points of RDI (≥5 and 10) was evaluated by the receiver operating characteristics (ROCs) curve.
RESULTS: The study included 114 patients (24 women; mean age and BMI, 59 years old and 33 kg/m(2); RDI and apnea/hypopnea index (AHI)-auto median, 5 and 2, respectively). The average difference between the AHI-auto and the RDI was -3.5 ± 3.9. The intraclass correlation coefficient (ICC) between the total number of central apneas, obstructive, and hypopneas between the PSG and the auto-CPAP were 0.69, 0.16, and 0.15, respectively. An AHI-auto >2 (RDI ≥ 5) or >4 (RDI ≥ 10) had an area under the ROC curve, sensitivity, specificity, positive likelihood ratio, and negative for diagnosis of residual sleep apnea of 0.84/0.89, 84/81%, 82/91%, 4.5/9.5, and 0.22/0.2, respectively.
CONCLUSIONS: The automatic analysis from auto-CPAP (S9 Autoset) showed a good diagnostic accuracy to identify residual sleep apnea. The absolute agreement between PSG and auto-CPAP to classify the respiratory events correctly varied from very low (obstructive apneas, hypopneas) to moderate (central apneas).

Entities:  

Mesh:

Year:  2014        PMID: 25115886     DOI: 10.1007/s11325-014-1048-z

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  19 in total

1.  Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

Authors:  E Shahar; C W Whitney; S Redline; E T Lee; A B Newman; F J Nieto; G T O'Connor; L L Boland; J E Schwartz; J M Samet
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

2.  Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults.

Authors:  T Young; J Blustein; L Finn; M Palta
Journal:  Sleep       Date:  1997-08       Impact factor: 5.849

3.  Non-Invasive detection of respiratory effort-related arousals (REras) by a nasal cannula/pressure transducer system.

Authors:  I Ayappa; R G Norman; A C Krieger; A Rosen; R L O'malley; D M Rapoport
Journal:  Sleep       Date:  2000-09-15       Impact factor: 5.849

4.  Prevalence of persistent sleep apnea in patients treated with continuous positive airway pressure.

Authors:  Marcel A Baltzan; Ibrahim Kassissia; Osama Elkholi; Mark Palayew; Richard Dabrusin; Norman Wolkove
Journal:  Sleep       Date:  2006-04       Impact factor: 5.849

5.  Evaluation of the apnea-hypopnea index determined by the S8 auto-CPAP, a continuous positive airway pressure device, in patients with obstructive sleep apnea-hypopnea syndrome.

Authors:  Kanako Ueno; Takatoshi Kasai; Gregory Brewer; Hisashi Takaya; Ken-ichi Maeno; Satoshi Kasagi; Fusae Kawana; Sugao Ishiwata; Koji Narui
Journal:  J Clin Sleep Med       Date:  2010-04-15       Impact factor: 4.062

6.  Follow-up assessment of CPAP efficacy in patients with obstructive sleep apnea using an ambulatory device based on peripheral arterial tonometry.

Authors:  Stephen D Pittman; Giora Pillar; Richard B Berry; Atul Malhotra; Mary M MacDonald; David P White
Journal:  Sleep Breath       Date:  2006-09       Impact factor: 2.816

7.  Comparison between the apnea-hypopnea indices determined by the REMstar Auto M series and those determined by standard in-laboratory polysomnography in patients with obstructive sleep apnea.

Authors:  Yukiko Ikeda; Takatoshi Kasai; Fusae Kawana; Satoshi Kasagi; Hisashi Takaya; Sugao Ishiwata; Koji Narui
Journal:  Intern Med       Date:  2012-10-15       Impact factor: 1.271

8.  Accuracy of autotitrating CPAP to estimate the residual Apnea-Hypopnea Index in patients with obstructive sleep apnea on treatment with autotitrating CPAP.

Authors:  Himanshu Desai; Anil Patel; Pinal Patel; Brydon J B Grant; M Jeffery Mador
Journal:  Sleep Breath       Date:  2009-05-01       Impact factor: 2.816

9.  Continuous positive airway pressure device-based automated detection of obstructive sleep apnea compared to standard laboratory polysomnography.

Authors:  Bharati Prasad; David W Carley; James J Herdegen
Journal:  Sleep Breath       Date:  2009-10-14       Impact factor: 2.816

10.  Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. An American Academy of Sleep Medicine report.

Authors:  Timothy I Morgenthaler; R Nisha Aurora; Terry Brown; Rochelle Zak; Cathy Alessi; Brian Boehlecke; Andrew L Chesson; Leah Friedman; Vishesh Kapur; Rama Maganti; Judith Owens; Jeffrey Pancer; Todd J Swick
Journal:  Sleep       Date:  2008-01       Impact factor: 5.849

View more
  9 in total

1.  Auto-CPAP: saving money as a single tool for OSA.

Authors:  Alberto Braghiroli; Giuseppe Insalaco; Antonio M Esquinas
Journal:  Sleep Breath       Date:  2015-08-27       Impact factor: 2.816

2.  Response to Braghiroli et al., regarding our study "Accuracy of a novel auto-CPAP device to evaluate the residual apnea-hypopnea index in patients with obstructive sleep apnea".

Authors:  Carlos A Nigro; Maria R Aragone
Journal:  Sleep Breath       Date:  2015-08-27       Impact factor: 2.816

3.  A longitudinal study of the accuracy of positive airway pressure therapy machine-detected apnea-hypopnea events.

Authors:  Yue-Nan Ni; Robert Joseph Thomas
Journal:  J Clin Sleep Med       Date:  2022-04-01       Impact factor: 4.062

4.  Use of the WatchPAT to detect occult residual sleep-disordered breathing in patients on CPAP for obstructive sleep apnea.

Authors:  Matthew Epstein; Tariq Musa; Stephanie Chiu; Jacquelyn Costanzo; Christine Dunne; Federico Cerrone; Robert Capone
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

5.  Interpreting CPAP device respiratory indices in children.

Authors:  Rebecca Mihai; Kirsten Ellis; Margot J Davey; Gillian M Nixon
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

6.  Oral appliance treatment outcome can be predicted by continuous positive airway pressure in moderate to severe obstructive sleep apnea.

Authors:  Anders Storesund; Anders Johansson; Bjørn Bjorvatn; Sverre Lehmann
Journal:  Sleep Breath       Date:  2017-10-24       Impact factor: 2.816

7.  A Patient with Heart Failure and Sleep-disordered Breathing Who Presented with Marked Reverse Remodeling by Continuous Positive Airway Pressure Therapy.

Authors:  Taishi Fukushima; Kenichiro Yasuda; Kazuo Eguchi; Masahiko Fujino; Haruo Kamiya
Journal:  Intern Med       Date:  2017-08-10       Impact factor: 1.271

8.  Evaluation of forced oscilometry technique's parameters in severe obstructive sleep apnea patients without breathing disorder.

Authors:  Besharat Rahimi; Maryam Edalatifard; Khosro Sadeghniiat Haghighi; Hossein Kazemzadeh
Journal:  J Family Med Prim Care       Date:  2020-03-26

9.  Analysis of risk factors for air leakage in auto-titrating positive airway pressure users: a single-center study.

Authors:  Yun Jin Kang; Jin-Hee Cho; Chan-Soon Park
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.